BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2092980)

  • 1. Systolic time intervals as indicators for cardiac function in rat models for heart failure.
    Schoemaker RG; Smits JF
    Eur Heart J; 1990 Dec; 11 Suppl I():114-23. PubMed ID: 2092980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Central and regional vascular hemodynamics of milrinone in experimental heart failure: comparison with captopril and dobutamine].
    Drexler H; Faude F; Winterer H; Wollschläger H; Freudenberg N; Just H
    Z Kardiol; 1987 Aug; 76(8):507-13. PubMed ID: 3314215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of systolic time intervals in hypertensive patients.
    Hamada M; Hiwada K; Kokubu T
    Eur Heart J; 1990 Dec; 11 Suppl I():105-13. PubMed ID: 2151186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
    Barraud D; Faivre V; Damy T; Welschbillig S; Gayat E; Heymes C; Payen D; Shah AM; Mebazaa A
    Crit Care Med; 2007 May; 35(5):1376-82. PubMed ID: 17414729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dobutamine on left ventricular performance in newborns as determined by systolic time intervals.
    Stopfkuchen H; Schranz D; Huth R; Jüngst BK
    Eur J Pediatr; 1987 Mar; 146(2):135-9. PubMed ID: 3569349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The left ventricular systolic function after digoxin administration in patients with chronic renal failure.
    Trznadel K; Luciak M; Wyszogrodzka M
    Clin Nephrol; 1980 May; 13(5):231-4. PubMed ID: 7398145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systolic mitral annulus velocity is a sensitive index for changes in left ventricular systolic function during inotropic therapy in patients with acute heart failure.
    Husebye T; Eritsland J; Bjørnerheim R; Andersen GØ
    Eur Heart J Acute Cardiovasc Care; 2018 Jun; 7(4):321-329. PubMed ID: 28045338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current views on Milrinon--a PDE-III-inhibitor].
    Anaesthesist; 1994 Mar; 43(3 Suppl):1-16. PubMed ID: 9209531
    [No Abstract]   [Full Text] [Related]  

  • 9. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
    Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systolic time intervals and ejection fraction in assessing left ventricular performance following acute myocardial infarction. Comparison of systolic time intervals and equilibrium radionuclide ventriculography.
    Mangschau A; Karlsen RL; Lippestad CT; Nerdrum HJ
    Acta Med Scand; 1984; 215(4):341-7. PubMed ID: 6233843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of a single dose of captopril on left-ventricular function in patients with chronic congestive cardiomyopathy].
    Markiewicz K; Górski L; Cholewa M; Dryjański T; Bratkowska B
    Kardiol Pol; 1989; 32(3):142-7. PubMed ID: 2695685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosuvastatin attenuates heart failure and cardiac remodelling in the ageing spontaneously hypertensive rat.
    Loch D; Chan V; Hoey A; Brown L
    Basic Clin Pharmacol Toxicol; 2009 Oct; 105(4):262-70. PubMed ID: 19583711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of dobutamine combined with intra-aortic balloon counterpulsation on left ventricular function early after acute myocardial infarction: experimental study.
    Toumanidis ST; Karapanos NT; Kottis G; Kaladaridou A; Bramos D; Trikka CO; Vasiladiotis N; Zakopoulos N; Moulopoulos SD
    Artif Organs; 2011 Sep; 35(9):875-82. PubMed ID: 21906094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of prolongation of pre-ejection period in the hypertrophied left ventricle with normal systolic function in unanesthetized hypertensive dogs.
    Matsuno Y; Morioka S; Murakami Y; Kobayashi S; Moriyama K
    Clin Cardiol; 1988 Oct; 11(10):702-6. PubMed ID: 3224453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive assessment of left ventricular effects of hydralazine in heart failure.
    Deglin SM; Jain AC; Harris WS
    Cardiology; 1980; 66(4):193-8. PubMed ID: 7448835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial and vascular effects of intracoronary versus intravenous milrinone.
    Colucci WS; Ludmer PL; Wright RF; Arnold JM; Ganz P; Braunwald E
    Trans Assoc Am Physicians; 1985; 98():136-45. PubMed ID: 3842193
    [No Abstract]   [Full Text] [Related]  

  • 17. Systolic time intervals in Duchenne muscular dystrophy: evaluation of left ventricular performance.
    Chenard AA; Becane HM; Tertrain F; Weiss YA
    Clin Cardiol; 1988 Jun; 11(6):407-11. PubMed ID: 3396241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining left ventricular systolic time intervals and M-mode echocardiography in the evaluation of primary pulmonary hypertension in women.
    Leier CV; Sahar D; Hermiller JB; Unverferth DV
    Clin Cardiol; 1985 Mar; 8(3):166-72. PubMed ID: 3156704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of sustained effects of levosimendan and dobutamine on left ventricular systolic functions by using novel tissue Doppler derived indices in patients with advanced heart failure.
    Oner E; Erturk M; Birant A; Kurtar Mansıroglu A; Akturk IF; Karakurt H; Yalcin AA; Uzun F; Somuncu MU; Yildirim A
    Cardiol J; 2015; 22(1):87-93. PubMed ID: 24846511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular impact of dobutamine in neonates with myocardial dysfunction.
    Robel-Tillig E; Knüpfer M; Pulzer F; Vogtmann C
    Early Hum Dev; 2007 May; 83(5):307-12. PubMed ID: 16982162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.